Boston Advisors’s Imperva, Inc. IMPV Stock Holding History

Boston Advisors’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-87,637	Closed	-$4.23M	–	682
2018 Q2	$4.23M	Sell	87,637 -12,352	-12%	-$591K	0.11%	207
2018 Q1	$4.33M	Buy	+99,989	New	+$4.49M	0.11%	202

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Advisors's IMPV Position: Q3 2018 in Review

Boston Advisors sold out of Imperva, Inc. (IMPV) in Q3 2018, closing a stake of 87,637 shares — an estimated $4.23M sold.

Boston Advisors first reported a position in IMPV in Q1 2018 and held it in 2 quarters. The position peaked at $4.33M in Q1 2018. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.

Boston Advisors reported no remaining Imperva, Inc. position as of Q3 2018 after selling out during the quarter.
Boston Advisors sold 87,637 Imperva, Inc. shares in Q3 2018, an estimated $4.23M.
Boston Advisors first reported a position in Imperva, Inc. in Q1 2018 and held it in 2 quarters.
Boston Advisors's Imperva, Inc. position peaked at $4.33M in Q1 2018.
168 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2018.

Based on Boston Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.